Aeterna Zentaris Reports Third Quarter Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Wall St futures rise ahead of jobs report as bond market steadies, oil slips
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- BofA’s Hartnett sees risk-off mood lasting until dollar peaks
- Fed’s Jefferson sees no urgency for another rate increase
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
UPDATE: Canaccord Genuity Upgrades AEterna Zentaris (AEZS) to Spec. Buy; Analyst Notes Removal of Dilution Overhang From Series B Warrants
November 9, 2015 6:42 AM EST(Updated - November 9, 2015 10:49 AM EST)
Canaccord Genuity upgraded Æterna Zentaris (NASDAQ: AEZS) from Hold to Spec. Buy with a price target of $0.10. Analyst Neil Maruoka said the agreement to exercise the majority of the Series B warrants substantially removes the single largest overhang for the stock. He also thinks Zoptrex pivotal data before the end of 2016 will major catalyst for the stock.
Maruoka explained, "Since Æterna Zentaris last reporting date, its stock price has continued to decline, losing ~66% of its value at the most recent closing price of US$0.057. We... More
Aeterna Zentaris (AEZS) Misses Q3 EPS by 1c
November 5, 2015 5:00 PM ESTAeterna Zentaris (NASDAQ: AEZS) reported Q3 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $0 versus the consensus estimate of $450 thousand.
For earnings history and earnings-related data on Aeterna Zentaris (AEZS) click here.
... More